Patents by Inventor Wilfred Jeffries

Wilfred Jeffries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P97 FRAGMENTS WITH TRANSFER ACTIVITY
    Publication number: 20150056218
    Abstract: The present invention is related to fragments of human melanotransferrin (p97). In particular, this invention relates to treatment of diseases through the introduction of the melanotransferrin fragment conjugated to a therapeutic or diagnostic agent to a subject.
    Type: Application
    Filed: March 26, 2014
    Publication date: February 26, 2015
    Applicant: biOasis Technologies, Inc.
    Inventors: Wilfred Jeffries, Mei Mei Tian, Timothy Vitalis
  • Caml-binding peptides
    Publication number: 20040219514
    Abstract: This invention provides peptides that bind to CAML, and nucleic acids encoding such peptides. These peptides and nucleic acids are useful for targeting CAML and for modulating of CAML activity so as to affect immune or inflammatory response or to evade apoptosis. Also provided are vectors for expressing such peptides and implantable medical devices comprising the peptides or nucleic acids.
    Type: Application
    Filed: November 24, 2003
    Publication date: November 4, 2004
    Inventors: Alexandru R. Moise, Wilfred A Jeffries, Timothy Z Vitalis, Jason R Grant
  • Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
    Publication number: 20020119095
    Abstract: The present invention provides pharmaceutical compositions of chemotherapeutic agents that demonstrate therapeutic efficacy against brain tumours and other neoplasia localized in or around the brain. In certain aspects, the pharmaceutical compositions comprise a chemotherapeutic agent conjugated to p97; and a pharmaceutically acceptable carrier therefor. Preferred chemotherapeutic agents include, but are not limited to, adriamycin, cisplatin, and paclitaxel.
    Type: Application
    Filed: August 17, 2001
    Publication date: August 29, 2002
    Inventors: Reinhard Gabathuler, Gerrassimos Kolaitis, Robert Charles Brooks, Qingqi Chen, Delara M. Karkan, Gavin D. Arthur, Jean Paul St. Pierre, Wilfred Jeffries, Timothy Z. Vitalis